Антигипертензивная терапия во вторичной профилактике
Abstract
About the Authors
В. ПарфеновRussian Federation
Ю. Старчина
Russian Federation
References
1. Парфенов В.А., Рыжак А.А. Неврологические аспекты оптимизации антигипертензивной терапиии. Невролог. журн. 2003; 2: 26–9.
2. Парфенов В.А., Старчина Ю.А., Яхно Н.Н. Эпросартан (Тевтен) в профилактике повторного инсульта и когнитивных нарушений. Там же. 2007; 1: 46–51.
3. Шевченко О.П., Праскурничий Е.А., Яхно Н.Н., Парфенов В.А. Артериальная гипертония и церебральный инсульт. М., 2001; 192.
4. Фейгин В., Виберс Д., Браун Р. Инсульт: Клиническое руководство. М.: Бином; Спб.: Диалект, 2005; 608.
5. Amarenco P, Bogousslavsky J, Amarenco P et al. High - dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–59.
6. Barnett H, Taylor D, Eliasziw M et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998; 339: 1415–25.
7. Chalmers J, Mac Mahon S, Anderson C et al. Clinician’s manual on blood pressure and stroke prevention. 2-d ed. London, 2000; 129.
8. Farmer J.A, Torre-Amione G. The renin - angiotensin system as a risk factor for coronary artery disease. Curr Atheroscler Rep 2001; 3: 117–24.
9. Post - stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J 1995; 108: 710–7.
10. PROGRESS Collaborative Group. Randomised trial of a perindopril - based blood - pressure - lowering regimen among 6105 individuals with previous stroke or transient schaemic attack. Lancet 2001; 358: 1033–41.
11. Rothwell P.M, Howard S.C, Spence J.D, for the Carotide Endarterectomy Trialist`s Collaboration. Relationship between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease. Stroke 2003; 34: 2583–92.
12. Sacco R.L, Adams R, Albers G et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577–617.
13. Schrader J, Luders S, Kulschewski A et al. Mortality and morbidity after stroke, Eprosartan compared with Nitrendipine for secondary prevention. Principal results of a prospective randomised controlled study (MOSES). Stroke 2005; 36: 1218–26.
Review
For citations:
, . Systemic Hypertension. 2007;(1):6-9.
Email this article 